1. Home
  2. TRIB vs NXL Comparison

TRIB vs NXL Comparison

Compare TRIB & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRIB

Trinity Biotech plc

HOLD

Current Price

$0.77

Market Cap

14.0M

Sector

Health Care

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.42

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRIB
NXL
Founded
1992
2010
Country
Ireland
United States
Employees
N/A
7
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0M
8.3M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
TRIB
NXL
Price
$0.77
$0.42
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
152.0K
211.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.51
$38.28
Revenue Next Year
$13.14
$185.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$0.37
52 Week High
$3.44
$2.57

Technical Indicators

Market Signals
Indicator
TRIB
NXL
Relative Strength Index (RSI) 53.26 38.72
Support Level $0.65 $0.42
Resistance Level $0.79 $0.62
Average True Range (ATR) 0.06 0.04
MACD 0.01 0.00
Stochastic Oscillator 84.28 9.31

Price Performance

Historical Comparison
TRIB
NXL

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: